Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

DaTSCAN Imaging in Aging and Neurodegenerative Disease

Authors not listed

Mayo Clinic · 2011

Abstract

The investigators propose using DaTscan in patients with REM sleep behavior disorder (RBD), mild cognitive impairment (MCI), Parkinson's disease (PD), dementia with Lewy bodies (DLB), Alzheimer's disease (AD), and other neurodegenerative syndromes and disorders, to test several hypotheses - some confirmatory, and some novel. Such use will provide new data on the potential clinical and research utility of DaTscan in neurodegenerative diseases. The findings on DaTscan will be correlated with clinical diagnoses and other multimodal imaging studies (e.g., MRI, MRS, FDG-PET, and amyloid-PET) to enhance our understanding of neurodegenerative diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-22 MST

Cite this

APA
Anonymous. (2011). DaTSCAN Imaging in Aging and Neurodegenerative Disease. <em>Mayo Clinic</em>. https://clinicaltrials.gov/study/NCT01453127
Vancouver
Anonymous. DaTSCAN Imaging in Aging and Neurodegenerative Disease. Mayo Clinic. 2011.
BibTeX
@misc{anon2011DaTSCA, title = {DaTSCAN Imaging in Aging and Neurodegenerative Disease}, author = {Anonymous}, journal = {Mayo Clinic}, year = {2011}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings